{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:47Z","timestamp":1790700227291,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T19:22:20Z","timestamp":1537644140000},"page":"739-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Postmenopausal osteoporosis: Assessment and management"],"prefix":"10.1016","volume":"32","author":[{"given":"Ren\u00e9","family":"Rizzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib2","first-page":"1","volume":"vol. 843","year":"1994"},{"key":"10.1016\/j.beem.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International osteoporosis foundation (IOF) and the European Federation of pharmaceutical industry associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.beem.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00198-008-0779-8","article-title":"Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women","volume":"20","author":"Lippuner","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bone.2006.12.063","article-title":"Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend","volume":"40","author":"Chevalley","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00198-005-0064-z","article-title":"Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists","volume":"17","author":"Casez","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jbmr.5650111215","article-title":"A\u00a0prospective study on socioeconomic aspects of fracture of the proximal femur","volume":"11","author":"Schurch","year":"1996","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00198-010-1487-8","article-title":"Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis","volume":"22","author":"Lippuner","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s001980200100","article-title":"Survival and potential years of life lost after hip fracture in men and age-matched women","volume":"13","author":"Trombetti","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib10","first-page":"1218","article-title":"Age- and menopause-related bone loss compromise cortical and trabecular microstructure","volume":"68","author":"Seeman","year":"2013","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.beem.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.beem.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrrheum.2014.188","article-title":"Glucocorticoid-induced osteoporosis: who to treat with what agent?","volume":"11","author":"Rizzoli","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.beem.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.beem.2014.08.003","article-title":"Nutritional aspects of bone health","volume":"28","author":"Rizzoli","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ejcn.2013.166","article-title":"A\u00a0critical pathway for the management of elderly inpatients with malnutrition: effects on serum insulin-like growth factor-I","volume":"67","author":"Trombetti","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.beem.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1532-5415.2009.02285.x","article-title":"Increasing dietary protein requirements in elderly people for optimal muscle and bone health","volume":"57","author":"Gaffney-Stomberg","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.beem.2018.09.005_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00198-006-0320-x","article-title":"Comparative effects of oral aromatic and branched-chain amino acids on urine calcium excretion in humans","volume":"18","author":"Dawson-Hughes","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.beem.2018.09.005_bib18","author":"Rizzoli","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2474-13-177","article-title":"Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials","volume":"13","author":"Kelley","year":"2012","journal-title":"BMC Muscoskel Disord"},{"key":"10.1016\/j.beem.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/bjsm.2008.052704","article-title":"A\u00a0meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes","volume":"43","author":"Martyn-St James","year":"2009","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.beem.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s00198-002-1345-4","article-title":"Bone strength and its determinants","volume":"14","author":"Ammann","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.beem.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/bonekey.2013.120","article-title":"Finite element analysis for prediction of bone strength","volume":"2","author":"Zysset","year":"2013","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.beem.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jbmr.3299","article-title":"Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women","volume":"33","author":"Biver","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for International reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","article-title":"A\u00a0meta-analysis of reference markers of bone turnover for prediction of fracture","volume":"94","author":"Johansson","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00223-014-9911-2","article-title":"Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of International cohorts","volume":"95","author":"Johansson","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00198-014-2755-9","article-title":"Management of osteoporosis of the oldest old","volume":"25","author":"Rizzoli","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","article-title":"Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland","volume":"23","author":"Lippuner","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.beem.2018.09.005_bib35","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2017.15006","article-title":"Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis","volume":"318","author":"Tricco","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib36","article-title":"Interventions for preventing falls in older people living in the community","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/bjsports-2016-096547","article-title":"Exercise to prevent falls in older adults: an updated systematic review and meta-analysis","volume":"51","author":"Sherrington","year":"2017","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.beem.2018.09.005_bib38","first-page":"2227","article-title":"Updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"American Geriatrics Society","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.beem.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinternmed.2010.446","article-title":"Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trial","volume":"171","author":"Trombetti","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00223-014-9907-y","article-title":"Long-term exercise in older adults: 4-year outcomes of music-based multitask training","volume":"95","author":"Hars","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.archger.2008.02.018","article-title":"A\u00a0systematic review of the effectiveness of Tai Chi on fall reduction among the elderly","volume":"48","author":"Low","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.beem.2018.09.005_bib42","first-page":"f6234","article-title":"The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"El-Khoury","year":"2013","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.beem.2018.09.005_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000333.pub2","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","author":"Howe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2018.09.005_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00223-015-9956-x","article-title":"Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials","volume":"96","author":"Girgis","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib45","doi-asserted-by":"crossref","DOI":"10.3402\/fnr.v52i0.1920","article-title":"Physical activity, muscle function, falls and fractures","volume":"52","author":"Karlsson","year":"2008","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.beem.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1249\/mss.0b013e3180616aa2","article-title":"Physical activity and public health in older adults: recommendation from the American college of sports medicine and the American heart association","volume":"39","author":"Nelson","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.beem.2018.09.005_bib47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3945\/ajcn.112.037556","article-title":"Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis","author":"Cermak","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2018.09.005_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/03007995.2013.766162","article-title":"Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)","volume":"29","author":"Rizzoli","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.beem.2018.09.005_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bone.2007.10.026","article-title":"Severe vitamin D deficiency in Swiss hip fracture patients","volume":"42","author":"Bischoff-Ferrari","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.005_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A\u00a0pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Bischoff-Ferrari","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib51","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2011-3328","article-title":"Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials","volume":"97","author":"Rejnmark","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.005_bib52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00198-010-1285-3","article-title":"IOF position statement: vitamin D recommendations for older adults","volume":"21","author":"Dawson-Hughes","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.005_bib54","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.beem.2018.09.005_bib56","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.beem.2018.09.005_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-012-2224-2","article-title":"Health risks and benefits from calcium and vitamin D supplementation: women's health initiative clinical trial and cohort study","volume":"24","author":"Prentice","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib58","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00198-014-2732-3","article-title":"Calcium supplement intake and risk of cardiovascular disease in women","volume":"25","author":"Paik","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-016-3773-6","volume":"28","author":"Harvey","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib60","doi-asserted-by":"crossref","first-page":"1256s","DOI":"10.3945\/ajcn.113.073056","article-title":"Dairy products, yogurts, and bone health","volume":"99","author":"Rizzoli","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2018.09.005_bib61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/ajcn.116.134676","article-title":"Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women","volume":"105","author":"Durosier-Izart","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2018.09.005_bib62","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-017-4285-8","article-title":"Milk and other dairy foods and risk of hip fracture in men and women","volume":"29","author":"Feskanich","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S8756-3282(03)00241-2","article-title":"Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial","volume":"33","author":"Delmas","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.005_bib65","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib67","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-010-1302-6","article-title":"Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial","volume":"22","author":"de Villiers","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/phar.1749","article-title":"Bazedoxifene and conjugated equine estrogen: a combination product for the management of vasomotor symptoms and osteoporosis prevention associated with menopause","volume":"36","author":"Umland","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.beem.2018.09.005_bib71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/qjmed\/hcq259","article-title":"Bisphosphonates for post-menopausal osteoporosis: are they all the same?","volume":"104","author":"Rizzoli","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.beem.2018.09.005_bib72","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.beem.2018.09.005_bib73","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2018.09.005_bib74","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib75","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/joim.12678","article-title":"Hip fracture risk and safety with alendronate treatment in the oldest-old","volume":"282","author":"Axelsson","year":"2017","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.09.005_bib76","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Rizzoli","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib77","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group","volume":"282","author":"Harris","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip intervention program study group","volume":"344","author":"McClung","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00198-012-2175-7","article-title":"Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years","volume":"24","author":"McClung","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib81","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib82","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study","volume":"15","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1185\/030079908X253717","article-title":"Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies","volume":"24","author":"Harris","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.beem.2018.09.005_bib84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2005.044958","article-title":"Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study","volume":"65","author":"Reginster","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2018.09.005_bib85","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.21918","article-title":"Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study","volume":"54","author":"Delmas","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beem.2018.09.005_bib86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00198-013-2518-z","article-title":"Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies","volume":"25","author":"Miller","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib87","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib88","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal fracture trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib90","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jbmr.2442","article-title":"The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal fracture trial (PFT)","volume":"30","author":"Black","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib92","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2018.09.005_bib93","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib94","doi-asserted-by":"crossref","first-page":"w14484","DOI":"10.4414\/smw.2017.14484","article-title":"Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO\/ASCO","volume":"147","author":"Meier","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.beem.2018.09.005_bib95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.005_bib96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semarthrit.2011.03.005","article-title":"Clinical efficacy and safety of denosumab in postmenopausal women with low bone mineral density and osteoporosis: a meta-analysis","volume":"41","author":"von Keyserlingk","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.beem.2018.09.005_bib97","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials","volume":"285","author":"Torgerson","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib98","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's health initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women's health initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2018.09.005_bib101","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib102","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment","volume":"20","author":"Prince","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.beem.2018.09.005_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.09.005_bib105","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/14656566.2017.1395021","article-title":"Abaloparatide Comparator Trial in Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis","volume":"18","author":"Reginster","year":"2017","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.beem.2018.09.005_bib106","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1210\/jc.2018-00163","article-title":"ACTIVExtend: 24 Months of alendronate after 18 Months of abaloparatide or placebo for postmenopausal osteoporosis","volume":"103","author":"Bone","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.005_bib107","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.005_bib108","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00223-016-0126-6","article-title":"Sclerostin inhibition in the management of osteoporosis","volume":"98","author":"Appelman-Dijkstra","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib109","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib110","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.005_bib111","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11657-013-0144-1","article-title":"SCOPE: a scorecard for osteoporosis in Europe","volume":"8","author":"Kanis","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.beem.2018.09.005_bib112","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1185\/03007995.2012.663750","article-title":"Long-term treatment of osteoporosis in postmenopausal women: a review from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) and the International osteoporosis foundation (IOF)","volume":"28","author":"Cooper","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.beem.2018.09.005_bib113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American society for bone and mineral research","volume":"31","author":"Adler","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00198-011-1796-6","article-title":"A\u00a0reappraisal of generic bisphosphonates in osteoporosis","volume":"23","author":"Kanis","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00223-011-9499-8","article-title":"Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis","volume":"89","author":"Rizzoli","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.09.005_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047616","article-title":"Bisphosphonates and risk of upper gastrointestinal cancer\u2013a case control study using the general practice research database (GPRD)","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2018.09.005_bib117","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.1792","article-title":"Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis","volume":"28","author":"Wolfe","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.005_bib118","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.005_bib119","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2018.09.005_bib120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-010-1453-5","article-title":"Subtrochanteric fractures after long-term treatment with bisphosphonates: a European society on clinical and economic aspects of osteoporosis and osteoarthritis, and International osteoporosis foundation working group report","volume":"22","author":"Rizzoli","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib121","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","article-title":"Increasing occurrence of atypical femoral fractures associated with bisphosphonate use","volume":"172","author":"Meier","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2018.09.005_bib122","article-title":"Understanding osteoporotic pain and its pharmacological treatment","author":"Vellucci","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib123","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00198-009-1134-4","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis","volume":"21","author":"Imaz","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.005_bib124","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s001980200053","article-title":"An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture","volume":"13","author":"Chevalley","year":"2002","journal-title":"Osteoporos Int"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:37Z","timestamp":1761497677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":124,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18301052"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmenopausal osteoporosis: Assessment and management","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}